Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
International Journal of Molecular Sciences
|
August 14, 2025
Omics-Mediated Treatment for Advanced Prostate Cancer: Moving Towards Precision Oncology
Yasra Fatima, Kirubel Nigusu Jobre, Enrique Gomez-Gomez, et al.
Scientific Reports
|
May 23, 2019
Urinary peptide panel for prognostic assessment of bladder cancer relapse
Magdalena Krochmal, Kim E M van Kessel, Ellen C Zwarthoff, et al.
Der Urologe. Ausg. A
|
June 22, 2021
[Diagnostic markers in urology]
Marie C Hupe, Marie C Hempel, Severin Rodler, et al.
Scientific Reports
|
May 12, 2016
Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of -omics findings
Agnieszka Latosinska, Manousos Makridakis, Maria Frantzi, et al.
Cancers
|
December 1, 2020
A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients' Omics Signatures
Marika Mokou, Vasiliki Lygirou, Ioanna Angelioudaki, et al.
Journal of Proteome Research
|
August 9, 2013
IMAC fractionation in combination with LC-MS reveals H2B and NIF-1 peptides as potential bladder cancer biomarkers
Maria Frantzi, Jerome Zoidakis, Theofilos Papadopoulos, et al.
Cancers
|
August 7, 2021
Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma
Ayman Bannaga, Jochen Metzger, Torsten Voigtländer, et al.
European Urology Oncology
|
May 1, 2025
Prediction of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy by Collagen Models Using Multiomic Profiles
Maria Frantzi, Piotr Tymoszuk, Stefan Salcher, et al.
Journal of Biomedical Science
|
January 5, 2020
Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma
Torsten Voigtländer, Jochen Metzger, Holger Husi, et al.
Proteomics
|
May 20, 2026
Peptidomic Profiling Reveals Extracellular Matrix Remodeling Signatures Discriminative of Multiple Myeloma
Maria Frantzi, Melika Ahangar, Antonia Vlahou, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
International Journal of Molecular Sciences
|
August 14, 2025
Omics-Mediated Treatment for Advanced Prostate Cancer: Moving Towards Precision Oncology
Yasra Fatima, Kirubel Nigusu Jobre, Enrique Gomez-Gomez, et al.
Scientific Reports
|
May 23, 2019
Urinary peptide panel for prognostic assessment of bladder cancer relapse
Magdalena Krochmal, Kim E M van Kessel, Ellen C Zwarthoff, et al.
Der Urologe. Ausg. A
|
June 22, 2021
[Diagnostic markers in urology]
Marie C Hupe, Marie C Hempel, Severin Rodler, et al.
Scientific Reports
|
May 12, 2016
Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of -omics findings
Agnieszka Latosinska, Manousos Makridakis, Maria Frantzi, et al.
Cancers
|
December 1, 2020
A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients' Omics Signatures
Marika Mokou, Vasiliki Lygirou, Ioanna Angelioudaki, et al.
Journal of Proteome Research
|
August 9, 2013
IMAC fractionation in combination with LC-MS reveals H2B and NIF-1 peptides as potential bladder cancer biomarkers
Maria Frantzi, Jerome Zoidakis, Theofilos Papadopoulos, et al.
Cancers
|
August 7, 2021
Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma
Ayman Bannaga, Jochen Metzger, Torsten Voigtländer, et al.
European Urology Oncology
|
May 1, 2025
Prediction of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy by Collagen Models Using Multiomic Profiles
Maria Frantzi, Piotr Tymoszuk, Stefan Salcher, et al.
Journal of Biomedical Science
|
January 5, 2020
Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma
Torsten Voigtländer, Jochen Metzger, Holger Husi, et al.
Proteomics
|
May 20, 2026
Peptidomic Profiling Reveals Extracellular Matrix Remodeling Signatures Discriminative of Multiple Myeloma
Maria Frantzi, Melika Ahangar, Antonia Vlahou, et al.
Page
of 6